Drugs / MCRcI®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04052191 | Dec 2025 → Jan 2026 overdue | coronary artery disorder | Honya Medical Inc | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCRcI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04052191 ↗ |
| Modality | Cell therapy | “MCRcI® stem cells” NCT04052191 ↗ |
| Route | Other | “Intra-Coronary Administration of MCRcI® stem cells” NCT04052191 ↗ |